During one-on-one medical consultations with our board-certified physicians and licensed providers who are experts in weight loss, patients discuss their weight loss goals and any concerns that they may have
GLP-1s for Chronic Kidney Disease GLP-1s for Advanced Liver Disease In August 2025, the FDA approved Wegovy (semaglutide) to treat adults with a type of liver disease called metabolic-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), when used alongside diet and exercise
Global healthcare firm Novo Nordisk, which makes Ozempic, told CNA it is unable to confirm whether product listings on third-party platforms are legitimate, as it only distributes to authorised sellers and not through online marketplaces
Paying attention to responsible gaming tools is equally essential: adjustable deposit caps, time reminders, and self-exclusion options are signs that a platform values long-term player wellbeing
However, more studies are needed to fully understand these differences and their implications for weight loss strategies
The information in this article shouldn't be used as a substitute for professional medical advice
.png)
